These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6333795)

  • 1. Assessment of primary gynecologic malignancies: comparison of 0.15-T resistive MRI with CT.
    Bies JR; Ellis JH; Kopecky KK; Sutton GP; Klatte EC; Stehman FB; Ehrlich CE
    AJR Am J Roentgenol; 1984 Dec; 143(6):1249-57. PubMed ID: 6333795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of MRI, CT and findings in staging of gynecologic malignancies].
    Lorenzen M; Braun J; Gehrckens A; Nicolas V
    Aktuelle Radiol; 1998 Nov; 8(6):266-72. PubMed ID: 9894525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of the abnormal female pelvis.
    Butler H; Bryan PJ; LiPuma JP; Cohen AM; El Yousef S; Andriole JG; Lieberman J
    AJR Am J Roentgenol; 1984 Dec; 143(6):1259-66. PubMed ID: 6388282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
    Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
    Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of X-ray CT and magnetic resonance imaging in the diagnosis of gynecological malignant tumor].
    Suzuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Aug; 41(8):942-52. PubMed ID: 2809344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gynecologic tumor].
    Kimura I; Togashi K; Konishi J; Taii S; Takai I; Mori T; Tamai T
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2172-81. PubMed ID: 2241181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI of the female pelvis: a review.
    Hricak H
    AJR Am J Roentgenol; 1986 Jun; 146(6):1115-22. PubMed ID: 3486556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone and liver metastases in uterine, cervical and ovarian cancer].
    Karkavitsas N
    Rontgenblatter; 1988 Aug; 41(8):326-8. PubMed ID: 3217713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of gynecologic malignancies.
    Ascher SM; Takahama J; Jha RC
    Top Magn Reson Imaging; 2001 Apr; 12(2):105-29. PubMed ID: 11296804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uterine cervical cancer: usefulness of MR imaging after the initial radiation therapy].
    Monzen Y; Mori H; Matsumoto A; Yoshida S; Wakisaka M; Komatsu E; Tashiro M; Hori Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Sep; 55(11):745-50. PubMed ID: 8532506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problem of pretherapeutic staging of cervical carcinoma. Studies of the diagnostic value of computerized tomography and magnetic resonance tomography in comparison with gynecologic palpation findings and pathologic-anatomic diagnosis].
    Zapf S; Halbsguth A; Schweden F; Klose K; Lochner B; Beck T; Friese K; Kreienberg R
    Geburtshilfe Frauenheilkd; 1987 Dec; 47(12):838-42. PubMed ID: 3436507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MRT diagnosis of recurrence of gynecologic tumors].
    Lorenzen M; Nicolas V; Kopp A
    Rofo; 1994 Dec; 161(6):526-30. PubMed ID: 7803776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiological assessment of gynecologic malignancies.
    Bell DJ; Pannu HK
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):45-68, vii. PubMed ID: 21419327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.
    Mitchell DG; Snyder B; Coakley F; Reinhold C; Thomas G; Amendola M; Schwartz LH; Woodward P; Pannu H; Hricak H
    J Clin Oncol; 2006 Dec; 24(36):5687-94. PubMed ID: 17179104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and interventional radiology in gynecologic neoplasms.
    Thorvinger B
    Acta Radiol Suppl; 1992; 378 ( Pt 3)():93-108. PubMed ID: 1323200
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET/CT, and PET/MR imaging.
    Lee SI; Catalano OA; Dehdashti F
    J Nucl Med; 2015 Mar; 56(3):436-43. PubMed ID: 25635136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance imaging (MRI) of the pelvis in the diagnosis of cervical carcinoma -- review].
    Hauth EA; Kimmig R; Forsting M
    Zentralbl Gynakol; 2006 Apr; 128(2):60-7. PubMed ID: 16673246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent female pelvic cancer: assessment with transrectal ultrasonography.
    Meanwell CA; Rolfe EB; Blackledge G; Docker MF; Lawton FG; Mould JJ
    Radiology; 1987 Jan; 162(1 Pt 1):278-81. PubMed ID: 3538149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnosis of computed tomography (CT) and magnetic resonance imaging (MRI) in evaluation of the extension of ovarian carcinoma].
    Mizuno K
    Rinsho Byori; 1992 Feb; 40(2):152-5. PubMed ID: 1583787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.